Table 1 Demographic characteristics of patients at baseline
Characteristics | All patients (n = 130) |
|---|---|
Age (years), mean (SD) | 54.74 (11.84) |
Gender, n (%) | |
Male | 101 (77.69) |
Female | 29 (22.31) |
Hypertension, n (%) | 81 (62.31) |
Diabetes mellitus, n (%) | 8 (6.15) |
COPD, n (%) | 6 (4.62) |
Stroke, n (%) | 8 (6.15) |
Coronary artery disease, n (%) | 7 (5.38) |
SBP (mmHg), mean (SD) | 133.63 (28.41) |
DBP (mmHg), mean (SD) | 72.92 (19.31) |
eGFR [ml/(min.1.73m2)], mean (SD) | 91.86 (40.27) |
Preoperative hemoglobin (g/l), mean (SD) | 122.96 (21.58) |
Emergency operation, n (%) | 88 (67.69) |
CPB time (min), median (IQR) | 193 (154–233) |
Aortic cross clamp time (min), median (IQR) | 101 (81–124) |
Circulatory arrest time (min), median (IQR) | 16 (0–24) |
Total arch replacement, n (%) | 76 (58.46) |
Semi-arch replacement, n (%) | 3 (2.31) |
Stented elephant trunk, n (%) | 72 (55.38) |
Bentall procedure, n (%) | 55 (42.31) |
Ascending aorta replacement, n (%) | 73 (56.15) |
David procedure, n (%) | 2 (1.54) |
Intraoperative erythrocytes use (ml), median (IQR) | 2300 (1300–3675) |
Intraoperative fresh frozen plasma use (ml), median (IQR) | 900 (550–1775) |
Intraoperative platelets use (ml), median (IQR) | 1200 (600–1200) |
Intraoperative cryoprecipitate use (ml), median (IQR) | 500 (213–519) |
Intraoperative blood transfusion (ml), median (IQR) | 4975 (2756–6819) |
Postoperative AKI, n (%) | 82 (63.08) |
Length of ICU (day) | 5.0 (3.0–10.0) |
Length of mechanical ventilation (day) | 2.5 (1.0–6.0) |
In-hospital mortality, n (%) | 21 (16.15) |